![Mark Sard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Sard
Directeur/Bestuurslid bij
LIRUM THERAPEUTICS, INC.
Profiel
Mark Sard is the founder.
He founded Frontier Equities VC LLC in 2011 as a Principal.
He is currently working as a Director at Lirum Therapeutics, Inc. since 2022.
Previously, he worked as a Director at Stemline Therapeutics, Inc. from 2018 to 2020.
Mr. Sard completed his undergraduate degree at the University of Pennsylvania.
Actieve functies van Mark Sard
| Bedrijven | Functie | Begin |
|---|---|---|
| LIRUM THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-11-2022 |
Frontier Equities VC LLC
 Frontier Equities VC LLC Investment ManagersFinance Frontier Equities seeks investment opportunities in early to mid-stage companies located in United States. The firm focuses across a wide array of sectors. | Oprichter | 01-01-2011 |
Eerdere bekende functies van Mark Sard
| Bedrijven | Functie | Einde |
|---|---|---|
| STEMLINE THERAPEUTICS, INC. | Directeur/Bestuurslid | 10-06-2020 |
Opleiding van Mark Sard
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
6
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Stemline Therapeutics, Inc.
 Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Frontier Equities VC LLC
Frontier Equities VC LLC Investment ManagersFinance Frontier Equities seeks investment opportunities in early to mid-stage companies located in United States. The firm focuses across a wide array of sectors. | Finance |
Lirum Therapeutics, Inc.
 Lirum Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that focuses on the treatment of debilitating diseases | Health Technology |
